Skip to main content

Helicobacter Pylori Infection News

Related terms: Pylori

Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD

THURSDAY, March 6, 2025 – For patients with gastroesophageal reflux disease (GERD), those with Helicobacter pylori infection have significantly lower rates of symptom rebound and rebound severity...

Clinical Practice Guideline Developed for Treatment of H. Pylori Infection

MONDAY, Sept. 9, 2024 – In a clinical practice guideline issued by the American College of Gastroenterology and published in the September issue of the American Journal of Gastroenterology,...

RedHill Announces FDA sNDA Approval for Simplified Dosage Regimen for Talicia

FDA approves supplemental new drug application (sNDA) for Talicia, changing dosing to a simplified three times daily (TID) regimen, which may support increased patient adherence and treatment...

FDA Approves Talicia (omeprazole magnesium, amoxicillin and rifabutin) for the Treatment of H. pylori Infection in Adults

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 04, 2019 (GLOBE NEWSWIRE) – RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Indigestion

Related drug support groups

amoxicillin, metronidazole, omeprazole, pantoprazole, Nexium, Flagyl, Pepto-Bismol, Prilosec, Protonix, clarithromycin, lansoprazole, tetracycline, esomeprazole